F. Wolfe et al., A PROSPECTIVE, LONGITUDINAL, MULTICENTER STUDY OF SERVICE UTILIZATIONAND COSTS IN FIBROMYALGIA, Arthritis and rheumatism, 40(9), 1997, pp. 1560-1570
Objective. To study, for the first time, service utilization and costs
in fibromyalgia, a prevalent syndrome associated with high levels of
pain, functional disability and emotional distress, Methods. Five hund
red thirty-eight fibromyalgia patients from 6 rheumatology centers wer
e enrolled in a 7-year prospective study of fibromyalgia outcome, Pati
ents were assessed every 6 months with validated, mailed questionnaire
s which included questions regarding fibromyalgia symptoms and severit
y, utilization of services, and work disability, Results, Fibromyalgia
patients averaged almost 10 outpatient medical visits per year, and w
hen nontraditional treatments were considered, this number increased t
o similar to 1 visit per month, Patients were hospitalized at a rate o
f 1 hospitalization every 3 years, In each 6-month study period, patie
nts used a mean of 2.7 fibromyalgia-related drugs. Costs increased ove
r the course of the study, The mean yearly per-patient cost in 1996 do
llars was $2,274. However, results were skewed by high utilizers, and
many patients used few services and had limited costs, Total costs and
utilization were independently associated with the number of self-rep
orted comorbid or associated conditions, functional disability, and gl
obal disease severity, Compared with patients with other rheumatic dis
orders, those with fibromyalgia were more likely to have lifetime surg
ical interventions, including hack or neck surgery, appendectomy, carp
al tunnel surgery, gynecologic surgery, abdominal surgery, and tonsill
ectomy, and were more likely than other rheumatic disease patients to
report comorbid or associated conditions, Almost 50% of hospitalizatio
ns occurring during the study were related to fibromyaigia-associated
symptoms. Conclusion, The average yearly cost for service utilization
among fibromyalgia patients is $2,274, Fibromyalgia patients have high
lifetime and current rates of utilization of all types of medical ser
vices, They report more symptoms and comorbid or associated conditions
than patients with other rheumatic conditions, and symptom reporting
is linked to service utilization and, to a lesser extent, functional d
isability and global disease severity.